The tumor microenvironment (TME) consists of mediators surrounding a tumor, including diverse cell types, blood vessels, and ...

Targeted cancer drugs known as CDK4/6 inhibitors have improved outcomes for patients with advanced or metastatic HR+/HER2- breast cancer, but many patients still eventually relapse and become ...

Dr. Vadim Jucaud's lab at the Terasaki Institute has developed a human vascularized liver cancer-on-a-chip model to evaluate vessel remodeling and cell death in response to embolic agents. This novel ...

A research team of Prof. Eijiro Miyako at the Japan Advanced Institute of Science and Technology (JAIST) has discovered that the bacterium Ewingella americana, isolated from the intestines of Japanese ...

Creating physiologically relevant conditions for cells that replicate in vivo environments can improve experimental results, ...

A multidisciplinary team integrated clinical need, cancer biology, and microfluidic bioengineering to advance ...

A newly identified cancer pathway may finally reveal how to stop pancreatic tumors before they spread. A Cornell-led research effort has uncovered how a highly aggressive type of pancreatic cancer is ...

Cancer imaging is entering a phase where malignant cells no longer hide in murky grayscale but flare into view with surgical ...

Chronic circadian disruption — such as night-shift work, irregular schedules, or frequent jet lag — accelerates the development and spread of aggressive breast cancer.